Find verified Canagliflozin Monohydrate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Canagliflozin Monohydrate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Canagliflozin Monohydrate API.
Alternate Names: Canagliflozina, UNII-B2L6AES9XQ
CAS No: 1809403-05-1
Mol Formula: C24H27FO6S
Mol Weight: 462.5 g/mol
IUPAC Name: (2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]meth l]-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol;hydrate - Show More
API Description: CANAGLIFLOZIN is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for diabetes mellitus and type 2 diabetes mellitus and has 7 investigational indications. This drug has a black box warning from the FDA.
Chongqing Carelife Pharmaceutical Co., Ltd. (CCPC) which is owned by YAOPHARMA Co., Ltd. is an internationalized and export-oriented high-tech enterprise. CCPC is mainly engaged in manufacturing and distribution of APIs and Intermediates.
